DECODE - Haemodynamic Effects Of Semaglutide and Tirzepatide - a Series of Pilot Studies
A phase 4 trial registered on ClinicalTrials.gov. The registry status is not yet recruiting. It plans to enroll 112 participants.
Also called NCT07483801
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; double masking; primary purpose basic science
- Phase
- Phase 4
- Enrolled
- 112 participants
- Registry
-
NCT07483801
-
- Planned start
- (anticipated)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- United Kingdom
- Registry status
- Not yet recruiting
Technical summary
Registry record NCT07483801. Randomized; double masking; primary purpose basic science. Start 2026-03 (anticipated); primary completion 2027-04 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- DECODE - Haemodynamic Effects Of Semaglutide and Tirzepatide - a Series of Pilot Studies
- Acronym
- DECODE
- Condition
- Cardiovascular Diseases
- Intervention (Drug)
- semaglutide
- Intervention (Drug)
- Tirzepatide
- Lead sponsor
- Cambridge University Hospitals NHS Foundation Trust
Record details
- Record id
cardio:ct-nct07483801- Content hash
ca6f6720019346bcaefa3eb8f5458324b6c34d5cd68962048b6b3244fa6e0c56